1
AMERCO
COM
UHAL
UHAL
139,352
$49.6m10.27%
10.27%
Reduced Shares held: Q4 2019 143.4k, Q1 2020 143.4k, Q2 2020 141.4k, Q3 2020 139.4k
-2.0k
-2,000
-1.4%
2
FPL GROUP INC
COM
COM
156,800
$43.5m9.01%
9.01%
Reduced Shares held: Q4 2019 196.8k, Q1 2020 186.8k, Q2 2020 166.8k, Q3 2020 156.8k
-10.0k
-10,000
-6.0%
3
APPLE INC
COM
AAPL
AAPL
290,400
$33.6m6.96%
6.96%
Added Shares held: Q4 2019 87.6k, Q1 2020 87.6k, Q2 2020 87.6k, Q3 2020 290.4k
+202.8k
+202,800
231.5%
4
CMS ENERGY CORP
COM
CMS
CMS
492,800
$30.3m6.27%
6.27%
Unchanged Shares held: Q4 2019 492.8k, Q1 2020 492.8k, Q2 2020 492.8k, Q3 2020 492.8k
5
XCEL ENERGY INC
COM
XEL
XEL
436,100
$30.1m6.23%
6.23%
Unchanged Shares held: Q4 2019 436.1k, Q1 2020 436.1k, Q2 2020 436.1k, Q3 2020 436.1k
6
ALLSTATE CORP
COM
ALL
ALL
309,800
$29.2m6.04%
6.04%
Unchanged Shares held: Q4 2019 309.8k, Q1 2020 309.8k, Q2 2020 309.8k, Q3 2020 309.8k
7
DUKE ENERGY CORP NEW
COM NEW
DUK
DUK
323,000
$28.6m5.92%
5.92%
Unchanged Shares held: Q4 2019 323.0k, Q1 2020 323.0k, Q2 2020 323.0k, Q3 2020 323.0k
8
ABBVIE INC
COM
ABBV
ABBV
322,549
$28.3m5.85%
5.85%
Unchanged Shares held: Q4 2019 257.8k, Q1 2020 257.8k, Q2 2020 322.5k, Q3 2020 322.5k
9
ABBOTT LABS
COM
ABT
ABT
254,600
$27.7m5.74%
5.74%
Unchanged Shares held: Q4 2019 254.6k, Q1 2020 254.6k, Q2 2020 254.6k, Q3 2020 254.6k
10
Merck & Co Inc
COM
COM
326,900
$27.1m5.62%
5.62%
Unchanged Shares held: Q4 2019 326.9k, Q1 2020 326.9k, Q2 2020 326.9k, Q3 2020 326.9k
11
VALEANT PHARMACEUTICALS INTL
COM
COM
1,427,000
$22.2m4.59%
4.59%
Added Shares held: Q4 2019 1.1m, Q1 2020 1.3m, Q2 2020 1.4m, Q3 2020 1.4m
+65.0k
+65,000
4.8%
12
PFIZER INC
COM
PFE
PFE
517,832
$19.0m3.94%
3.94%
Unchanged Shares held: Q4 2019 517.8k, Q1 2020 517.8k, Q2 2020 517.8k, Q3 2020 517.8k
13
Paratek
CV 4.75% · principal
CV 4.75% · principal
16,800,000
$13.9m2.89%
2.89%
Unchanged Principal held: Q4 2019 16.8m, Q1 2020 16.8m, Q2 2020 16.8m, Q3 2020 16.8m
14
INTERNATIONAL BUSINESS MACHS
COM
IBM
IBM
113,450
$13.8m2.86%
2.86%
Reduced Shares held: Q4 2019 114.5k, Q1 2020 114.0k, Q2 2020 114.0k, Q3 2020 113.5k
-550
-550
-0.5%
15
COMPASS MINERALS INTL INC
COM
CMP
CMP
140,000
$8.3m1.72%
1.72%
Unchanged Shares held: Q4 2019 140.0k, Q1 2020 140.0k, Q2 2020 140.0k, Q3 2020 140.0k
16
SUPERNUS PHARMACEUTICALS INC
COM
SUPN
SUPN
352,105
$7.3m1.52%
1.52%
Unchanged Shares held: Q4 2019 352.1k, Q1 2020 352.1k, Q2 2020 352.1k, Q3 2020 352.1k
17
SIRIUS XM HOLDINGS INC
COM
SIRI
SIRI
1,357,843
$7.3m1.50%
1.50%
Unchanged Shares held: Q4 2019 1.4m, Q1 2020 1.4m, Q2 2020 1.4m, Q3 2020 1.4m
18
ACORDA THERAPEUTICS INC
NOTE 1.750% 6/1 · principal
ACOR 1.75 06.15.21 · principal
ACOR 1.75 06.15.21
11,500,000
$7.2m1.50%
1.50%
Unchanged Principal held: Q4 2019 11.5m, Q1 2020 11.5m, Q2 2020 11.5m, Q3 2020 11.5m
19
AVISTA CORP
COM
AVA
AVA
208,500
$7.1m1.47%
1.47%
Unchanged Shares held: Q4 2019 208.5k, Q1 2020 208.5k, Q2 2020 208.5k, Q3 2020 208.5k
20
GENERAL ELECTRIC CO
COM
COM
1,050,000
$6.5m1.35%
1.35%
Unchanged Shares held: Q4 2019 850.0k, Q1 2020 1.1m, Q2 2020 1.1m, Q3 2020 1.1m
21
PARATEK PHARMACEUTICALS INC
COM
PRTK
PRTK
879,312
$4.8m0.99%
0.99%
Added Shares held: Q4 2019 266.6k, Q1 2020 466.6k, Q2 2020 566.6k, Q3 2020 879.3k
+312.8k
+312,760
55.2%
22
CHEVRON CORP NEW
COM
CVX
CVX
58,600
$4.2m0.87%
0.87%
Unchanged Shares held: Q4 2019 0, Q1 2020 3.0k, Q2 2020 58.6k, Q3 2020 58.6k
23
NEWMONT CORP
COM
NEM
NEM
65,000
$4.1m0.85%
0.85%
Unchanged Shares held: Q4 2019 65.0k, Q1 2020 65.0k, Q2 2020 65.0k, Q3 2020 65.0k
24
FATE THERAPEUTICS INC
COM
FATE
FATE
100,000
$4.0m0.83%
0.83%
Unchanged Shares held: Q4 2019 50.0k, Q1 2020 50.0k, Q2 2020 100.0k, Q3 2020 100.0k
25
EDAP TMS S A
SPONSORED ADR
FOCL
FOCL
825,536
$3.8m0.79%
0.79%
Unchanged Shares held: Q4 2019 825.5k, Q1 2020 825.5k, Q2 2020 825.5k, Q3 2020 825.5k
26
Mannkind
CV 5.75% · principal
CV 5.75% · principal
5,000,000
$3.8m0.78%
0.78%
Unchanged Principal held: Q4 2019 5.0m, Q1 2020 5.0m, Q2 2020 5.0m, Q3 2020 5.0m
27
Bunge
CONV PREF
BG 4.875 PERP
BG 4.875 PERP
27,400
$2.6m0.55%
0.55%
Unchanged Shares held: Q4 2019 27.4k, Q1 2020 27.4k, Q2 2020 27.4k, Q3 2020 27.4k
28
Rocket
CV 6.25% · principal
RCKT 6.25 08.01.22 · principal
RCKT 6.25 08.01.22
2,000,000
$2.2m0.46%
0.46%
Unchanged Principal held: Q4 2019 0, Q1 2020 0, Q2 2020 2.0m, Q3 2020 2.0m
29
CHIASMA INC
COM
CHMA
CHMA
450,000
$1.9m0.40%
0.40%
New Shares held: Q4 2019 0, Q1 2020 0, Q2 2020 0, Q3 2020 450.0k
30
RLI CORP
COM
RLI
RLI
22,800
$1.9m0.40%
0.40%
Unchanged Shares held: Q4 2019 22.8k, Q1 2020 22.8k, Q2 2020 22.8k, Q3 2020 22.8k
31
ASHLAND INC NEW
COM
COM
25,000
$1.8m0.37%
0.37%
Unchanged Shares held: Q4 2019 25.0k, Q1 2020 25.0k, Q2 2020 25.0k, Q3 2020 25.0k
32
Acorda Theraputics
CV 6.0% · principal
CV 6.0% · principal
2,500,000
$1.4m0.28%
0.28%
Unchanged Principal held: Q4 2019 0, Q1 2020 2.5m, Q2 2020 2.5m, Q3 2020 2.5m
33
VALVOLINE INC
COM
VVV
VVV
68,633
$1.3m0.27%
0.27%
Unchanged Shares held: Q4 2019 68.6k, Q1 2020 68.6k, Q2 2020 68.6k, Q3 2020 68.6k
34
FLOTEK INDS INC DEL
COM
COM
466,671
$1.3m0.26%
0.26%
Reduced Shares held: Q4 2019 711.7k, Q1 2020 711.7k, Q2 2020 711.7k, Q3 2020 466.7k
-245.0k
-245,000
-34.4%
35
NOVAVAX INC
NOTE 3.750% 2/0 · principal
NVAX 3.75 02.01.23 · principal
NVAX 3.75 02.01.23
1,000,000
$1.1m0.24%
0.24%
Reduced Principal held: Q4 2019 3.0m, Q1 2020 3.0m, Q2 2020 3.0m, Q3 2020 1.0m
-2.0m
-2,000,000
-66.7%
36
Team
CV 5% · principal
CV 5% · principal
1,000,000
$800.0k0.17%
0.17%
Unchanged Principal held: Q4 2019 1.0m, Q1 2020 1.0m, Q2 2020 1.0m, Q3 2020 1.0m
37
EXXON MOBIL CORP
COM
XOM
XOM
12,684
$441.0k0.09%
0.09%
Unchanged Shares held: Q4 2019 5.2k, Q1 2020 10.2k, Q2 2020 12.7k, Q3 2020 12.7k
38
KELLOGG CO
COM
K
K
4,436
$286.0k0.06%
0.06%
Unchanged Shares held: Q4 2019 4.4k, Q1 2020 4.4k, Q2 2020 4.4k, Q3 2020 4.4k
39
MANNKIND CORP
COM NEW
MNKD
MNKD
135,094
$253.0k0.05%
0.05%
Reduced Shares held: Q4 2019 1.4m, Q1 2020 175.7k, Q2 2020 635.1k, Q3 2020 135.1k
-500.0k
-500,000
-78.7%
40
XTNT
COMMON
COMMON
182,972
$150.0k0.03%
0.03%
Unchanged Shares held: Q4 2019 183.0k, Q1 2020 183.0k, Q2 2020 183.0k, Q3 2020 183.0k
41
WISCONSIN ENERGY CORP
COM
COM
564
$54.0k0.01%
0.01%
Unchanged Shares held: Q4 2019 23.1k, Q1 2020 13.1k, Q2 2020 564, Q3 2020 564